Clinical, phenotypic and genetic similarities and disparities between post-transplant and classical Hodgkin lymphomas with respect to therapeutic targets

Author： Adams Heiner   Campidelli Cristina   Dirnhofer Stephan   Pileri Stefano A   Tzankov Alexandar  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.13, Iss.10, 2009-10, pp. : 1137-1145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Calcineurin Inhibitors and Post-Transplant Hyperlipidaemias

By Moore R.  

Drug Safety, Vol. 24, Iss. 10, 2001-01 ,pp. : 755-766

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of post-transplant viral infections

By Sun Hsin-Yun   Singh Nina  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 14, 2008-10 ,pp. : 2409-2421

Informa Healthcare

Access to resources Recommend Favorite

Radioimmunotherapy of Non-Hodgkin's Lymphomas

By  

Current Drug Targets, Vol. 7, Iss. 10, 2006-10 ,pp. : 1293-1300

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Hodgkin's Lymphomas

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 4, 2008-04 ,pp. : 356-356

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Emerging therapeutic targets in tuberculosis: post-genomic era

By Khasnobis Shampa   Escuyer Vincent E   Chatterjee Delphi  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 1, 2002-02 ,pp. : 21-40

Informa Healthcare

Access to resources Recommend Favorite